These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14577038)

  • 21. Continuation of hormone replacement therapy after hysterectomy.
    Domoney C; Studd JW; Mocroft A
    Climacteric; 2003 Mar; 6(1):58-66. PubMed ID: 12725666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
    Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
    Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant.
    Goulet RJ; Phan AD; Cantor LB; WuDunn D
    Ophthalmology; 2008 Jul; 115(7):1141-7. PubMed ID: 18164068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
    Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Argon laser peripheral iridoplasty in the management of phacomorphic glaucoma.
    Yip PP; Leung WY; Hon CY; Ho CK
    Ophthalmic Surg Lasers Imaging; 2005; 36(4):286-91. PubMed ID: 16156144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S
    Maturitas; 2006 Nov; 55(4):308-16. PubMed ID: 16730140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal changes in subjective and objective visual function 5 years after cataract surgery Prospective population-based study.
    Lundqvist B; Mönestam E
    J Cataract Refract Surg; 2006 Nov; 32(11):1944-50. PubMed ID: 17081901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cataract phacoemulsification and intraocular pressure in glaucoma patients.
    Mierzejewski A; Eliks I; Kałuzny B; Zygulska M; Harasimowicz B; Kałuzny JJ
    Klin Oczna; 2008; 110(1-3):11-7. PubMed ID: 18669076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
    Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
    Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trabeculotomy combined with phacoemulsification and implantation of intraocular lens for primary open-angle glaucoma.
    Mizoguchi T; Kuroda S; Terauchi H; Nagata M
    Semin Ophthalmol; 2001 Sep; 16(3):162-7. PubMed ID: 15513436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of physicians' advice and recommendations on the compliance with hormone replacement therapy in the treatment of postmenopausal symptoms in Japanese women--a prospective study.
    Ushiroyama T; Ikeda A; Sakuma K; Ueki M
    J Med; 2004; 35(1-6):163-9. PubMed ID: 18084874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with intention to use hormone replacement therapy among Thai middle-aged women.
    Burusanont M; Hadsall RS
    Maturitas; 2004 Mar; 47(3):219-27. PubMed ID: 15036492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and vision-related quality of life in the early manifest glaucoma trial.
    Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
    Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Traumatic cataract--treatment results].
    Woś M; Mirkiewicz-Sieradzka B
    Klin Oczna; 2004; 106(1-2):31-4. PubMed ID: 15218761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of hormone replacement therapy on blood antioxidant enzymes in menopausal women.
    Unfer TC; Conterato GM; da Silva JC; Duarte MM; Emanuelli T
    Clin Chim Acta; 2006 Jul; 369(1):73-7. PubMed ID: 16472795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women.
    Maddalozzo GF; Widrick JJ; Cardinal BJ; Winters-Stone KM; Hoffman MA; Snow CM
    Bone; 2007 May; 40(5):1244-51. PubMed ID: 17291843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation.
    Paganelli F; Cardillo JA; Melo LA; Oliveira AG; Skaf M; Costa RA;
    Ophthalmology; 2004 Nov; 111(11):2102-8. PubMed ID: 15522378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone replacement therapy and cognition in an Australian representative sample aged 60-64 years.
    Low LF; Anstey KJ; Jorm AF; Christensen H; Rodgers B
    Maturitas; 2006 Apr; 54(1):86-94. PubMed ID: 16226000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal replacement therapy after stem cell transplantation.
    Piccioni P; Scirpa P; D'Emilio I; Sora F; Scarciglia M; Laurenti L; De Matteis S; Sica S; Leone G; Chiusolo P
    Maturitas; 2004 Dec; 49(4):327-33. PubMed ID: 15531129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.